Literature DB >> 27554199

Increased diffusivity in gray matter in recent onset schizophrenia is associated with clinical symptoms and social cognition.

Jung Sun Lee1, Chang-Yoon Kim2, Yeon Ho Joo2, Dominick Newell3, Sylvain Bouix3, Martha E Shenton4, Marek Kubicki5.   

Abstract

INTRODUCTION: Diffusion weighted MRI (dMRI) is a method sensitive to pathological changes affecting tissue microstructure. Most dMRI studies in schizophrenia, however, have focused solely on white matter. There is a possibility, however, that subtle changes in diffusivity exist in gray matter (GM). Accordingly, we investigated diffusivity in GM in patients with recent onset schizophrenia.
METHODS: We enrolled 45 patients and 21 age and sex-matched healthy controls. All subjects were evaluated using the short form of the Wechsler Adult Intelligence Scale, the Positive and Negative Syndrome Scale (PANSS), and the video based social cognition scale. DMRI and T1W images were acquired on a 3 Tesla magnet, and mean Fractional Anisotropy (FA), Trace (TR) and volume were calculated for each of the 68 cortical GM Regions of Interest parcellated using FreeSurfer.
RESULTS: There was no significant difference of FA and GM volume between groups after Bonferroni correction. For the dMRI measures, however, patients evinced increased TR in the left bank of the superior temporal sulcus, the right inferior parietal, the right inferior temporal, and the right middle temporal gyri. In addition, higher TR in the right middle temporal gyrus and the right inferior temporal gyrus, respectively, was associated with decreased social function and higher PANSS score in patients with schizophrenia.
CONCLUSION: This study demonstrates high sensitivity of dMRI to subtle pathology in GM in recent onset schizophrenia, as well as an association between increased diffusivity in temporal GM regions and abnormalities in social cognition and exacerbation of psychiatric symptoms.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diffusivity; Gray matter; MRI; Schizophrenia

Mesh:

Year:  2016        PMID: 27554199      PMCID: PMC5392041          DOI: 10.1016/j.schres.2016.08.011

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  98 in total

1.  Clinical use of diffusion-tensor imaging for diseases causing neuronal and axonal damage.

Authors:  A M Uluğ; D F Moore; A S Bojko; R D Zimmerman
Journal:  AJNR Am J Neuroradiol       Date:  1999 Jun-Jul       Impact factor: 3.825

Review 2.  The neurobiology of social cognition.

Authors:  R Adolphs
Journal:  Curr Opin Neurobiol       Date:  2001-04       Impact factor: 6.627

3.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

4.  The effects of gender on grey matter abnormalities in major psychoses: a comparative voxelwise meta-analysis of schizophrenia and bipolar disorder.

Authors:  E Bora; A Fornito; M Yücel; C Pantelis
Journal:  Psychol Med       Date:  2011-08-11       Impact factor: 7.723

Review 5.  The application of DTI to investigate white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Carl-Fredrik Westin; Robert W McCarley; Martha E Shenton
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

Review 6.  Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review.

Authors:  Yaniv Assaf; Ofer Pasternak
Journal:  J Mol Neurosci       Date:  2008       Impact factor: 3.444

Review 7.  Temporal lobe asymmetries as the key to the etiology of schizophrenia.

Authors:  T J Crow
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

8.  A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia.

Authors:  S Muñoz Maniega; G K S Lymer; M E Bastin; D Marjoram; D E Job; T W J Moorhead; D G Owens; E C Johnstone; A M McIntosh; S M Lawrie
Journal:  Schizophr Res       Date:  2008-10-11       Impact factor: 4.939

9.  Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI study.

Authors:  Toshiaki Onitsuka; Martha E Shenton; Dean F Salisbury; Chandlee C Dickey; Kiyoto Kasai; Sarah K Toner; Melissa Frumin; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

10.  White matter microstructure in schizophrenia: effects of disorder, duration and medication.

Authors:  Richard Kanaan; Gareth Barker; Michael Brammer; Vincent Giampietro; Sukhwinder Shergill; James Woolley; Marco Picchioni; Timothea Toulopoulou; Philip McGuire
Journal:  Br J Psychiatry       Date:  2009-03       Impact factor: 9.319

View more
  4 in total

1.  Additive Burden of Abnormal Diffusivity in the Brain with Schizophrenia: A Diffusion Tensor Imaging Study with Public Neuroimaging Data.

Authors:  Young Tak Jo; Jungsun Lee; Sung Woo Joo; Harin Kim; Seung-Hyun Shon; Woon Yoon; Youjin Hong
Journal:  Psychiatry Investig       Date:  2020-04-08       Impact factor: 2.505

2.  Associations of Neurocognition and Social Cognition With Brain Structure and Function in Early-Onset Schizophrenia.

Authors:  Pengfei Guo; Shuwen Hu; Xiaolu Jiang; Hongyu Zheng; Daming Mo; Xiaomei Cao; Jiajia Zhu; Hui Zhong
Journal:  Front Psychiatry       Date:  2022-02-10       Impact factor: 4.157

3.  Abnormal network homogeneity of default-mode network and its relationships with clinical symptoms in antipsychotic-naïve first-diagnosis schizophrenia.

Authors:  Mingjun Kong; Tian Chen; Shuzhan Gao; Sulin Ni; Yidan Ming; Xintong Chai; Chenxi Ling; Xijia Xu
Journal:  Front Neurosci       Date:  2022-07-25       Impact factor: 5.152

4.  The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.

Authors:  Shlomo Sragovich; Anna Malishkevich; Yael Piontkewitz; Eliezer Giladi; Olga Touloumi; Roza Lagoudaki; Nikolaos Grigoriadis; Illana Gozes
Journal:  Transl Psychiatry       Date:  2019-01-15       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.